153 related articles for article (PubMed ID: 9174621)
61. Importance of tumor necrosis factor-alpha cleavage process in post-transplantation lung injury in rats.
Goto T; Ishizaka A; Kobayashi F; Kohno M; Sawafuji M; Tasaka S; Ikeda E; Okada Y; Maruyama I; Kobayashi K
Am J Respir Crit Care Med; 2004 Dec; 170(11):1239-46. PubMed ID: 15333331
[TBL] [Abstract][Full Text] [Related]
62. Acute alcohol inhibits TNF-alpha processing in human monocytes by inhibiting TNF/TNF-alpha-converting enzyme interactions in the cell membrane.
Zhao XJ; Marrero L; Song K; Oliver P; Chin SY; Simon H; Schurr JR; Zhang Z; Thoppil D; Lee S; Nelson S; Kolls JK
J Immunol; 2003 Mar; 170(6):2923-31. PubMed ID: 12626543
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain.
Gonzales PE; Solomon A; Miller AB; Leesnitzer MA; Sagi I; Milla ME
J Biol Chem; 2004 Jul; 279(30):31638-45. PubMed ID: 15100227
[TBL] [Abstract][Full Text] [Related]
64. Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.
Lu Z; Ott GR; Anand R; Liu RQ; Covington MB; Vaddi K; Qian M; Newton RC; Christ DD; Trzaskos J; Duan JJ
Bioorg Med Chem Lett; 2008 Mar; 18(6):1958-62. PubMed ID: 18282708
[TBL] [Abstract][Full Text] [Related]
65. Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
Rabinowitz MH; Andrews RC; Becherer JD; Bickett DM; Bubacz DG; Conway JG; Cowan DJ; Gaul M; Glennon K; Lambert MH; Leesnitzer MA; McDougald DL; Moss ML; Musso DL; Rizzolio MC
J Med Chem; 2001 Nov; 44(24):4252-67. PubMed ID: 11708926
[TBL] [Abstract][Full Text] [Related]
66. The active site of a zinc-dependent metalloproteinase influences the computed pK(a) of ligands coordinated to the catalytic zinc ion.
Cross JB; Duca JS; Kaminski JJ; Madison VS
J Am Chem Soc; 2002 Sep; 124(37):11004-7. PubMed ID: 12224947
[TBL] [Abstract][Full Text] [Related]
67. Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.
Levin JI; Chen JM; Du MT; Nelson FC; Killar LM; Skala S; Sung A; Jin G; Cowling R; Barone D; March CJ; Mohler KM; Black RA; Skotnicki JS
Bioorg Med Chem Lett; 2002 Apr; 12(8):1199-202. PubMed ID: 11934588
[TBL] [Abstract][Full Text] [Related]
68. Inhibition of the metalloproteinase domain of mouse TACE.
Amour A; Hutton M; Knäuper V; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Docherty AJ; Murphy G
Ann N Y Acad Sci; 1999 Jun; 878():728-31. PubMed ID: 10415820
[No Abstract] [Full Text] [Related]
69. New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors.
Barlaam B; Bird TG; Lambert-Van Der Brempt C; Campbell D; Foster SJ; Maciewicz R
J Med Chem; 1999 Nov; 42(23):4890-908. PubMed ID: 10579851
[TBL] [Abstract][Full Text] [Related]
70. Regulation of tumor necrosis factor-alpha and tumor necrosis factor converting enzyme in human osteoarthritis.
Amin AR
Osteoarthritis Cartilage; 1999 Jul; 7(4):392-4. PubMed ID: 10419777
[TBL] [Abstract][Full Text] [Related]
71. Benzodiazepine inhibitors of the MMPs and TACE. Part 2.
Levin JI; Nelson FC; Delos Santos E; Du MT; MacEwan G; Chen JM; Ayral-Kaloustian S; Xu J; Jin G; Cummons T; Barone D
Bioorg Med Chem Lett; 2004 Aug; 14(16):4147-51. PubMed ID: 15261259
[TBL] [Abstract][Full Text] [Related]
72. Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch.
Buckley CA; Rouhani FN; Kaler M; Adamik B; Hawari FI; Levine SJ
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1132-8. PubMed ID: 15749738
[TBL] [Abstract][Full Text] [Related]
73. Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.
Xue CB; Chen XT; He X; Roderick J; Corbett RL; Ghavimi B; Liu RQ; Covington MB; Qian M; Ribadeneira MD; Vaddi K; Trzaskos J; Newton RC; Duan JJ; Decicco CP
Bioorg Med Chem Lett; 2004 Sep; 14(17):4453-9. PubMed ID: 15357971
[TBL] [Abstract][Full Text] [Related]
74. Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.
Levin JI; Chen JM; Laakso LM; Du M; Du X; Venkatesan AM; Sandanayaka V; Zask A; Xu J; Xu W; Zhang Y; Skotnicki JS
Bioorg Med Chem Lett; 2005 Oct; 15(19):4345-9. PubMed ID: 16084720
[TBL] [Abstract][Full Text] [Related]
75. Gelastatins and their hydroxamates as dual functional inhibitors for TNF-alpha converting enzyme and matrix metalloproteinases: synthesis, biological evaluation, and mechanism studies.
Park SK; Han SB; Lee K; Lee HJ; Kho YH; Chun H; Choi Y; Yang JY; Yoon YD; Lee CW; Kim HM; Choi HM; Tae HS; Lee HY; Nam KY; Han G
Biochem Biophys Res Commun; 2006 Mar; 341(2):627-34. PubMed ID: 16438938
[TBL] [Abstract][Full Text] [Related]
76. Targeted overexpression of transmembrane tumor necrosis factor provokes a concentric cardiac hypertrophic phenotype.
Dibbs ZI; Diwan A; Nemoto S; DeFreitas G; Abdellatif M; Carabello BA; Spinale FG; Feuerstein G; Sivasubramanian N; Mann DL
Circulation; 2003 Aug; 108(8):1002-8. PubMed ID: 12912811
[TBL] [Abstract][Full Text] [Related]
77. HDLs activate ADAM17-dependent shedding.
Tellier E; Canault M; Poggi M; Bonardo B; Nicolay A; Alessi MC; Nalbone G; Peiretti F
J Cell Physiol; 2008 Mar; 214(3):687-93. PubMed ID: 17786981
[TBL] [Abstract][Full Text] [Related]
78. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes.
Crowe PD; Walter BN; Mohler KM; Otten-Evans C; Black RA; Ware CF
J Exp Med; 1995 Mar; 181(3):1205-10. PubMed ID: 7869036
[TBL] [Abstract][Full Text] [Related]
79. A pathogenic trace of Tannerella forsythia - shedding of soluble fully active tumor necrosis factor α from the macrophage surface by karilysin.
Bryzek D; Ksiazek M; Bielecka E; Karim AY; Potempa B; Staniec D; Koziel J; Potempa J
Mol Oral Microbiol; 2014 Dec; 29(6):294-306. PubMed ID: 25175980
[TBL] [Abstract][Full Text] [Related]
80. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE).
Milla ME; Leesnitzer MA; Moss ML; Clay WC; Carter HL; Miller AB; Su JL; Lambert MH; Willard DH; Sheeley DM; Kost TA; Burkhart W; Moyer M; Blackburn RK; Pahel GL; Mitchell JL; Hoffman CR; Becherer JD
J Biol Chem; 1999 Oct; 274(43):30563-70. PubMed ID: 10521439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
